Targeting proteasomes with naturally occurring compounds in cancer treatment

Current Cancer Drug Targets

Volumn 11, Issue 3, 2011, Pages 307-324

  Cecarini, V ^a   Cuccioloni, M ^a   Mozzicafreddo, M ^a   Bonfili, L ^a   Angeletti, M ^a   Eleuteri, A M ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

Author keywords

Apoptosis; Cancer; Polyphenols; Proteasome

Indexed keywords

5,6,4' TRIHYDROXY 7,3' DIMETHOXYFLAVONE; 6,7,4' TRIHYDROXYISOFLAVONE; APIGENIN; APIGENIN 6 HYDROXY; APIGENIN 6 HYDROXY 7 O BETA DEXTRO GLUCOSIDE; CAPSAICIN; CELASTROL; CHLOROGENIC ACID; CURCUMIN; DELPHINIDIN; DNA; GLYCITEIN; KAEMPFEROL; MALVIDIN 3 GALACTOSIDE; MALVIDIN CHLORIDE; MALVIN; MYRTILLIN; OENIN; PEDALITIN; PELARGONIDIN; PELARGONIN; PEONIDIN; PEONIDIN 3 GLUCOSIDE; PETUNIDIN CHLORIDE; POLYPHENOL; PROTEASOME; QUERCETIN; RUTOSIDE; SUMATRANOSIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ANTINEOPLASTIC AGENT; BIOLOGICAL PRODUCT; PROTEINASE INHIBITOR;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER CELL; CANCER PREVENTION; CANCER THERAPY; COLON CANCER; DNA REPAIR; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG STRUCTURE; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; NONHUMAN; ANIMAL; DRUG ANTAGONISM; METABOLISM; NEOPLASM; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL PRODUCTS; HUMANS; NEOPLASMS; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX;

EID: 79951708401     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/156800911794519815     Document Type: Article

References (108)

1. Ciechanover, A. The ubiquitin-proteasome pathway: on proteindeath and cell life. EMBO J. 1998, 17(24), 7151-7160.
2. Ciechanover, A. Intracellular protein degradation: from a vagueidea thru the lysosome and the ubiquitin-proteasome system andonto human diseases and drug targeting. Cell Death Differ. 2005,12(9), 1178-1190.
3. Jung, T.; Catalgol, B.; Grune, T. The proteasomal system. Mol.Aspects Med. 2009, 30(4), 191-296.
4. Baumeister, W.; Walz, J.; Zuhl, F.; Seemuller, E. The proteasome:paradigm of a self-compartmentalizing protease. Cell 1998, 92(3),367-380.
5. Groll, M.; Ditzel, L.; Lowe, J.; Stock, D.; Bochtler, M.; Bartunik, H. D.; Huber, R. Structure of 20S proteasome from yeast at 2.4 Aresolution. Nature 1997, 386(6624), 463-471.
6. Lowe, J.; Stock, D.; Jap, B.; Zwickl, P.; Baumeister, W.; Huber, R. Crystal structure of the 20S proteasome from the archaeon T. acidophilumat 3.4 A resolution. Science 1995, 268(5210), 533-539.
7. Orlowski, M.; Cardozo, C.; Michaud, C. Evidence for the presence of five distinct proteolytic components in the pituitary multicatalyticproteinase complex. Properties of two components cleavingbonds on the carboxyl side of branched chain and small neutralamino acids. Biochemistry 1993, 32(6), 1563-1572.
8. Groll, M.; Bochtler, M.; Brandstetter, H.; Clausen, T.; Huber, R. Molecular machines for protein degradation. ChemBioChem 2005,6(2), 222-256.
9. Seemuller, E.; Lupas, A.; Stock, D.; Lowe, J.; Huber, R.; Baumeister, W. Proteasome from Thermoplasma acidophilum: a threonineprotease. Science 1995, 268(5210), 579-582.
10. Aki, M.; Shimbara, N.; Takashina, M.; Akiyama, K.; Kagawa, S.; Tamura, T.; Tanahashi, N.; Yoshimura, T.; Tanaka, K.; Ichihara, A. Interferon-gamma induces different subunit organizations and functionaldiversity of proteasomes. J. Biochem. 1994, 115(2), 257-269.
11. Llovera, M.; Garcia-Martinez, C.; Agell, N.; Lopez-Soriano, F. J.; Argiles, J. M. TNF can directly induce the expression of ubiquitindependentproteolytic system in rat soleus muscles. Biochem. Biophys.Res. Commun. 1997, 230(2), 238-241.
12. Nelson, J. E.; Loukissa, A.; Altschuller-Felberg, C.; Monaco, J. J.; Fallon, J. T.; Cardozo, C. Up-regulation of the proteasome subunit LMP7 in tissues of endotoxemic rats. J. Lab. Clin. Med. 2000,135(4), 324-331.
13. Fehling, H. J.; Swat, W.; Laplace, C.; Kuhn, R.; Rajewsky, K.; Muller, U.; von Boehmer, H. MHC class I expression in mice lackingthe proteasome subunit LMP-7. Science 1994, 265(5176),1234-1237.
14. Ciechanover, A.; Orian, A.; Schwartz, A. L. The ubiquitinmediated proteolytic pathway: mode of action and clinical implications.J. Cell. Biochem. Suppl. 2000, 34, 40-51.
15. An, B.; Goldfarb, R. H.; Siman, R.; Dou, Q. P. Novel dipeptidylproteasome inhibitors overcome Bcl-2 protective function and selectivelyaccumulate the cyclin-dependent kinase inhibitor p27 andinduce apoptosis in transformed, but not normal, human fibroblasts. Cell Death Differ. 1998, 5(12), 1062-1075.
16. Lopes, U. G.; Erhardt, P.; Yao, R.; Cooper, G. M. p53-dependentinduction of apoptosis by proteasome inhibitors. J. Biol. Chem.1997, 272(20), 12893-12896.
17. Voorhees, P. M.; Dees, E. C.; O'Neil, B.; Orlowski, R. Z. Theproteasome as a target for cancer therapy. Clin. Cancer Res. 2003,9(17), 6316-6325.
18. Wojcik, C. Regulation of apoptosis by the ubiquitin and proteasomepathway. J. Cell. Mol. Med. 2002, 6(1), 25-48.
19. Chene, P. Inhibiting the p53-MDM2 interaction: an importanttarget for cancer therapy. Nat. Rev. Cancer 2003, 3(2), 102-109.
20. Concannon, C. G.; Koehler, B. F.; Reimertz, C.; Murphy, B. M.; Bonner, C.; Thurow, N.; Ward, M. W.; Villunger, A.; Strasser, A.; Kogel, D.; Prehn, J. H. Apoptosis induced by proteasome inhibitionin cancer cells: predominant role of the p53/PUMA pathway. Oncogene 2007, 26(12), 1681-1692.
21. Sheikh, M. S.; Fornace, A. J., Jr. Role of p53 family members inapoptosis. J. Cell. Physiol. 2000, 182(2), 171-181.
22. Kisselev, A. F.; Goldberg, A. L. Proteasome inhibitors: from researchtools to drug candidates. Chem. Biol. 2001, 8(8), 739-758.
23. Kropff, M.; Bisping, G.; Wenning, D.; Berdel, W. E.; Kienast, J. Proteasome inhibition in multiple myeloma. Eur. J. Cancer 2006,42(11), 1623-1639.
24. Ludwig, H.; Khayat, D.; Giaccone, G.; Facon, T. Proteasome inhibitionand its clinical prospects in the treatment of hematologic andsolid malignancies. Cancer 2005, 104(9), 1794-1807.
25. Bonfili, L.; Cecarini, V.; Amici, M.; Cuccioloni, M.; Angeletti, M.; Keller, J. N.; Eleuteri, A. M. Natural polyphenols as proteasomemodulators and their role as anti-cancer compounds. FEBS J. 2008,275(22), 5512-5526.
26. Ovaskainen, M. L.; Torronen, R.; Koponen, J. M.; Sinkko, H.; Hellstrom, J.; Reinivuo, H.; Mattila, P. Dietary intake and majorfood sources of polyphenols in Finnish adults. J. Nutr. 2008,138(3), 562-566.
27. Arts, I. C.; Hollman, P. C. Polyphenols and disease risk in epidemiologicstudies. Am. J. Clin. Nutr. 2005, 81 (1 Suppl), 317S-325S.
28. Mukhtar, H.; Ahmad, N. Tea polyphenols: prevention of cancerand optimizing health. Am. J. Clin. Nutr. 2000, 71(6 Suppl),1698S-1702S; discussion 1703S-1694S.
29. Erba, D.; Riso, P.; Bordoni, A.; Foti, P.; Biagi, P. L.; Testolin, G. Effectiveness of moderate green tea consumption on antioxidativestatus and plasma lipid profile in humans. J. Nutr. Biochem. 2005,16(3), 144-149.
30. Dalluge, J. J.; Nelson, B. C.; Thomas, J. B.; Sander, L. C. Selectionof column and gradient elution system for the separation of catechinsin green tea using high-performance liquid chromatography.J. Chromatogr. A 1998, 793(2), 265-274.
31. Jin, C. Y.; Lee, J. D.; Park, C.; Choi, Y. H.; Kim, G. Y. Curcuminattenuates the release of pro-inflammatory cytokines in lipopolysaccharide-stimulated BV2 microglia. Acta Pharmacol. Sin. 2007,28(10), 1645-1651.
32. Kunnumakkara, A. B.; Anand, P.; Aggarwal, B.B. Curcumin inhibitsproliferation, invasion, angiogenesis and metastasis of differentcancers through interaction with multiple cell signaling proteins.Cancer Lett. 2008, 269(2), 199-225.
33. Khan, N.; Afaq, F.; Mukhtar, H. Cancer chemoprevention throughdietary antioxidants: progress and promise. Antioxid. Redox Signal.2008, 10(3), 475-510.
34. Milacic, V.; Banerjee, S.; Landis-Piwowar, K. R.; Sarkar, F. H.; Majumdar, A. P.; Dou, Q.P. Curcumin inhibits the proteasome activityin human colon cancer cells in vitro and in vivo. Cancer Res.2008, 68(18), 7283-7292.
35. Jana, N. R.; Dikshit, P.; Goswami, A.; Nukina, N. Inhibition ofproteasomal function by curcumin induces apoptosis through mitochondrialpathway. J. Biol. Chem. 2004, 279(12), 11680-11685.
36. Dikshit, P.; Goswami, A.; Mishra, A.; Nukina, N.; Jana, N.R. Curcumin enhances the polyglutamine-expanded truncated Nterminalhuntingtin-induced cell death by promoting proteasomalmalfunction. Biochem. Biophys. Res. Commun. 2006, 342(4), 1323-1328.
37. Ali, R. E.; Rattan, S. I. Curcumin's biphasic hormetic response onproteasome activity and heat-shock protein synthesis in humankeratinocytes. Ann. N. Y. Acad. Sci. 2006, 1067, 394-399.
38. Si, X.; Wang, Y.; Wong, J.; Zhang, J.; McManus, B. M.; Luo, H. Dysregulation of the ubiquitin-proteasome system by curcuminsuppresses coxsackievirus B3 replication. J. Virol. 2007, 81(7),3142-3150.
39. Padhye, S.; Yang, H.; Jamadar, A.; Cui, Q. C.; Chavan, D.; Dominiak, K.; McKinney, J.; Banerjee, S.; Dou, Q. P.; Sarkar, F.H. New difluoro Knoevenagel condensates of curcumin, their Schiff bases and copper complexes as proteasome inhibitors and apoptosis inducers in cancer cells. Pharm. Res. 2009, 26(8), 1874-1880.
40. Chen, D.; Daniel, K. G.; Chen, M. S.; Kuhn, D. J.; Landis-Piwowar, K. R.; Dou, Q. P. Dietary flavonoids as proteasome inhibitorsand apoptosis inducers in human leukemia cells. Biochem.Pharmacol. 2005, 69(10), 1421-1432.
41. Chen, D.; Landis-Piwowar, K. R.; Chen, M. S.; Dou, Q. P. Inhibitionof proteasome activity by the dietary flavonoid apigenin is associatedwith growth inhibition in cultured breast cancer cells andxenografts. Breast Cancer Res. 2007, 9(6), R80.
42. Wu, Y. X.; Fang, X. Apigenin, chrysin, and luteolin selectivelyinhibit chymotrypsin-like and trypsin-like proteasome catalytic activitiesin tumor cells. Planta Med. 2010, 76(2), 128-132.
43. Dosenko, V. E.; Nagibin, V. S.; Tumanovskaia, L. V.; Zagorii,VIu; Moibenko, A. A. [The influence of quercetin on the activity ofpurified 20S, 26S proteasome and proteasomal activity in isolatedcardiomyocytes]. Biomed. Khim. 2006, 52(2), 138-145.
44. Chang, T. L. Inhibitory Effect of Flavonoids on 26S ProteasomeActivity. J. Agric. Food. Chem. 2009, 57, 9706-9715.
45. Way, T. D.; Kao, M. C.; Lin, J. K. Apigenin induces apoptosisthrough proteasomal degradation of HER2/neu in HER2/neuoverexpressingbreast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway. J. Biol. Chem. 2004, 279(6), 4479-4489.
46. Siegelin, M. D.; Reuss, D. E.; Habel, A.; Herold-Mende, C.; vonDeimling, A. The flavonoid kaempferol sensitizes human gliomacells to TRAIL-mediated apoptosis by proteasomal degradation ofsurvivin. Mol. Cancer Ther. 2008, 7(11), 3566-3574.
47. Siegelin, M. D.; Reuss, D. E.; Habel, A.; Rami, A.; von Deimling,A. Quercetin promotes degradation of survivin and thereby enhancesdeath-receptor-mediated apoptosis in glioma cells. NeuroOncol. 2009, 11(2), 122-131.
48. Son, Y. G.; Kim, E. H.; Kim, J. Y.; Kim, S. U.; Kwon, T. K.;Yoon, A. R.; Yun, C. O.; Choi, K. S. Silibinin sensitizes humanglioma cells to TRAIL-mediated apoptosis via DR5 up-regulationand down-regulation of c-FLIP and survivin. Cancer Res. 2007,67(17), 8274-8284.
49. Chang, T. L.; Ding, H. Y.; Teng, K. N.; Fang, Y. C. 5,6,3',4'-Tetrahydroxy-7-methoxyflavone as a Novel Potential ProteasomeInhibitor. Planta Med. 2010, 76(10), 987-94.
50. Dreiseitel, A.; Schreier, P.; Oehme, A.; Locher, S.; Rogler, G.;Piberger, H.; Hajak, G.; Sand, P. G. Inhibition of proteasome activityby anthocyanins and anthocyanidins. Biochem. Biophys. Res.Commun. 2008, 372(1), 57-61.
51. Zheng, W.; Wang, S. Y. Oxygen radical absorbing capacity ofphenolics in blueberries, cranberries, chokeberries, and lingonberries.J. Agric. Food. Chem. 2003, 51(2), 502-509.
52. Wang, H.; Nair, M. G.; Strasburg, G. M.; Chang, Y. C.; Booren, A.M.; Gray, J. I.; DeWitt, D. L. Antioxidant and antiinflammatory activitiesof anthocyanins and their aglycon, cyanidin, from tart cherries.J. Nat. Prod. 1999, 62(2), 294-296.
53. Hou, D. X. Potential mechanisms of cancer chemoprevention byanthocyanins. Curr. Mol. Med. 2003, 3(2), 149-159.
54. Sweeney, M. I.; Kalt, W.; MacKinnon, S. L.; Ashby, J.; Gottschall-Pass, K. T. Feeding rats diets enriched in lowbush blueberries forsix weeks decreases ischemia-induced brain damage. Nutr. Neurosci.2002, 5(6), 427-431.
55. Tarozzi, A.; Morroni, F.; Hrelia, S.; Angeloni, C.; Marchesi, A.;Cantelli-Forti, G.; Hrelia, P. Neuroprotective effects of anthocyaninsand their in vivo metabolites in SH-SY5Y cells. Neurosci. Lett.2007, 424(1), 36-40.
56. Kim, H. G.; Ju, M. S.; Shim, J. S.; Kim, M. C.; Lee, S. H.; Huh, Y.;Kim, S. Y.; Oh, M. S. Mulberry fruit protects dopaminergic neuronsin toxin-induced Parkinson's disease models. Br. J. Nutr.2010, 1-9.
57. Pajonk, F.; Scholber, J.; Fiebich, B. Hypericin-an inhibitor of proteasomefunction. Cancer Chemother. Pharmacol. 2005, 55(5),439-446.
58. Manju, V.; Nalini, N. Protective role of luteolin in 1,2-dimethylhydrazine induced experimental colon carcinogenesis. CellBiochem. Funct. 2007, 25(2), 189-194.
59. Bagli, E.; Stefaniotou, M.; Morbidelli, L.; Ziche, M.; Psillas, K.;Murphy, C.; Fotsis, T. Luteolin inhibits vascular endothelial growthfactor-induced angiogenesis; inhibition of endothelial cell survivaland proliferation by targeting phosphatidylinositol 3'-kinase activity.Cancer Res. 2004, 64(21), 7936-7946.
60. Leung, H. W.; Wu, C. H.; Lin, C. H.; Lee, H. Z. Luteolin induced DNA damage leading to human lung squamous carcinoma CH27 cell apoptosis. Eur. J. Pharmacol. 2005, 508(1-3), 77-83.
61. Selvendiran, K.; Koga, H.; Ueno, T.; Yoshida, T.; Maeyama, M.;Torimura, T.; Yano, H.; Kojiro, M.; Sata, M. Luteolin promotesdegradation in signal transducer and activator of transcription 3 inhuman hepatoma cells: an implication for the antitumor potential offlavonoids. Cancer Res. 2006, 66(9), 4826-4834.
62. Shi, R. X.; Ong, C. N.; Shen, H. M. Luteolin sensitizes tumor necrosisfactor-alpha-induced apoptosis in human tumor cells. Oncogene, 2004, 23(46), 7712-7721.
63. Katsiki, M.; Chondrogianni, N.; Chinou, I.; Rivett, A. J.; Gonos, E.S. The olive constituent oleuropein exhibits proteasome stimulatoryproperties in vitro and confers life span extension of human embryonicfibroblasts. Rejuvenation Res. 2007, 10(2), 157-172.
64. Liu, E. H.; Qi, L. W.; Wu, Q.; Peng, Y. B.; Li, P. Anticancer agentsderived from natural products. Mini Rev. Med. Chem. 2009, 9(13),1547-1555.
65. Liao, H. F.; Kuo, C. D.; Yang, Y. C.; Lin, C. P.; Tai, H. C.; Chen,Y. Y.; Chen, Y. J. Resveratrol enhances radiosensitivity of humannon-small cell lung cancer NCI-H838 cells accompanied by inhibitionof nuclear factor-kappa B activation. J. Radiat. Res. (Tokyo)2005, 46(4), 387-393.
66. Marambaud, P.; Zhao, H.; Davies, P. Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. J. Biol. Chem.2005, 280(45), 37377-37382.
67. Pettinari, A.; Amici, M.; Cuccioloni, M.; Angeletti, M.; Fioretti, E.;Eleuteri, A. M. Effect of polyphenolic compounds on the proteolyticactivities of constitutive and immuno-proteasomes. Antioxid.Redox Signal. 2006, 8(1-2), 121-129.
68. Mozzicafreddo, M.; Cuccioloni, M.; Cecarini, V.; Eleuteri, A. M.;Angeletti, M. Homology modeling and docking analysis of the interactionbetween polyphenols and mammalian 20S proteasomes. J.Chem. Inf. Model. 2009, 49(2), 401-409.
69. Nam, S.; Smith, D. M.; Dou, Q. P. Tannic acid potently inhibitstumor cell proteasome activity, increases p27 and Bax expression,and induces G1 arrest and apoptosis. Cancer Epidemiol. BiomarkersPrev. 2001, 10(10), 1083-1088.
70. Cichocki, M.; Blumczynska, J.; Baer-Dubowska, W. Naturallyoccurring phenolic acids inhibit 12-O-tetradecanoylphorbol-13-acetate induced NF-kappaB, iNOS and COX-2 activation in mouseepidermis. Toxicology 2010, 268(1-2), 118-124.
71. Chen, M. S.; Chen, D.; Dou, Q. P. Inhibition of proteasome activity by various fruits and vegetables is associated with cancer cell death. In Vivo 2004, 18(1), 73-80.
72. Kazi, A.; Urbizu, D. A.; Kuhn, D. J.; Acebo, A. L.; Jackson, E. R.;Greenfelder, G. P.; Kumar, N. B.; Dou, Q. P. A natural musaceasplant extract inhibits proteasome activity and induces apoptosis selectivelyin human tumor and transformed, but not normal and nontransformed,cells. Int. J. Mol. Med. 2003, 12(6), 879-887.
73. Amici, M.; Bonfili, L.; Spina, M.; Cecarini, V.; Calzuola, I.; Marsili,V.; Angeletti, M.; Fioretti, E.; Tacconi, R.; Gianfranceschi, G.L.; Eleuteri, A. M. Wheat sprout extract induces changes on 20S proteasomes functionality. Biochimie 2008, 90(5), 790-801.
74. Bonfili, L.; Amici, M.; Cecarini, V.; Cuccioloni, M.; Tacconi, R.;Angeletti, M.; Fioretti, E.; Keller, J. N.; Eleuteri, A. M. Wheat sprout extract-induced apoptosis in human cancer cells by proteasomes modulation. Biochimie 2009, 91(9), 1131-1144.
75. Menendez, J. A.; Vazquez-Martin, A.; Garcia-Villalba, R.; Carrasco-Pancorbo, A.; Oliveras-Ferraros, C.; Fernandez-Gutierrez,A.; Segura-Carretero, A. tabAnti-HER2 (erbB-2) oncogene effects of phenolic compounds directly isolated from commercial Extra-Virgin Olive Oil (EVOO). BMC Cancer 2008, 8, 377.
76. Llobet, D.; Eritja, N.; Encinas, M.; Sorolla, A.; Yeramian, A.;Schoenenberger, J. A.; Llombart-Cussac, A.; Marti, R. M.; Matias-Guiu, X.; Dolcet, X. Antioxidants block proteasome inhibitor functionin endometrial carcinoma cells. Anticancer Drugs 2008, 19(2), 115-124.
77. Perrone, G.; Hideshima, T.; Ikeda, H.; Okawa, Y.; Calabrese, E.;Gorgun, G.; Santo, L.; Cirstea, D.; Raje, N.; Chauhan, D.; Baccarani,M.; Cavo, M.; Anderson, K. C. Ascorbic acid inhibits antitumoractivity of bortezomib in vivo. Leukemia 2009, 23(9), 1679-1686.
78. Liu, F. T.; Agrawal, S. G.; Movasaghi, Z.; Wyatt, P. B.; Rehman, I.U.; Gribben, J. G.; Newland, A. C.; Jia, L. Dietary flavonoids inhibitthe anticancer effects of the proteasome inhibitor bortezomib. Blood 2008, 112(9), 3835-3846.
79. Kim, T. Y.; Park, J.; Oh, B.; Min, H. J.; Jeong, T. S.; Lee, J. H.;Suh, C.; Cheong, J. W.; Kim, H. J.; Yoon, S. S.; Park, S. B.; Lee,D. S. Natural polyphenols antagonize the antimyeloma activity ofproteasome inhibitor bortezomib by direct chemical interaction. Br.J. Haematol. 2009, 146(3), 270-281.
80. Golden, E. B.; Lam, P. Y.; Kardosh, A.; Gaffney, K. J.; Cadenas,E.; Louie, S. G.; Petasis, N. A.; Chen, T. C.; Schonthal, A. H.Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood 2009, 113(23), 5927-5937.
81. Chauhan, D.; Hideshima, T.; Anderson, K. C. A novel proteasomeinhibitor NPI-0052 as an anticancer therapy. Br. J. Cancer 2006,95(8), 961-965.
82. Singh, A. V.; Palladino, M. A.; Lloyd, G. K.; Potts, B. C.;Chauhan, D.; Anderson, K. C. Pharmacodynamic and efficacystudies of the novel proteasome inhibitor NPI-0052 (marizomib) ina human plasmacytoma xenograft murine model. Br. J. Haematol.2010, 149(4), 550-559.
83. Wang, W.; McLeod, H. L.; Cassidy, J. Disulfiram-mediated inhibitionof NF-kappaB activity enhances cytotoxicity of 5-fluorouracilin human colorectal cancer cell lines. Int. J. Cancer 2003, 104(4),504-511.
84. Brar, S. S.; Grigg, C.; Wilson, K. S.; Holder, W. D., Jr.; Dreau, D.;Austin, C.; Foster, M.; Ghio, A. J.; Whorton, A. R.; Stowell, G. W.;Whittall, L. B.; Whittle, R. R.; White, D. P.; Kennedy, T. P. Disulfiraminhibits activating transcription factor/cyclic AMPresponsiveelement binding protein and human melanoma growthin a metal-dependent manner in vitro, in mice and in a patient withmetastatic disease. Mol. Cancer Ther. 2004, 3(9), 1049-1060.
85. Cen, D.; Gonzalez, R. I.; Buckmeier, J. A.; Kahlon, R. S.; Tohidian,N. B.; Meyskens, F. L., Jr. Disulfiram induces apoptosis inhuman melanoma cells: a redox-related process. Mol. Cancer Ther.2002, 1(3), 197-204.
86. Shian, S. G.; Kao, Y. R.; Wu, F. Y.; Wu, C. W. Inhibition of invasionand angiogenesis by zinc-chelating agent disulfiram. Mol.Pharmacol. 2003, 64(5), 1076-1084.
87. Chauhan, D.; Catley, L.; Li, G.; Podar, K.; Hideshima, T.; Velankar,M.; Mitsiades, C.; Mitsiades, N.; Yasui, H.; Letai, A.; Ovaa,H.; Berkers, C.; Nicholson, B.; Chao, T. H.; Neuteboom, S. T.;Richardson, P.; Palladino, M. A.; Anderson, K. C. A novel orallyactive proteasome inhibitor induces apoptosis in multiple myelomacells with mechanisms distinct from Bortezomib. Cancer Cell.2005, 8(5), 407-419.
88. Groll, M.; Huber, R.; Potts, B. C. Crystal structures of SalinosporamideA (NPI-0052) and B (NPI-0047) in complex with the 20Sproteasome reveal important consequences of beta-lactone ringopening and a mechanism for irreversible binding. J. Am. Chem.Soc. 2006, 128(15), 5136-5141.
89. Su, B. N.; Hwang, B. Y.; Chai, H.; Carcache-Blanco, E. J.; Kardono,L. B.; Afriastini, J. J.; Riswan, S.; Wild, R.; Laing, N.;Farnsworth, N. R.; Cordell, G. A.; Swanson, S. M.; Kinghorn, A.D. Activity-guided fractionation of the leaves of Ormosia sumatranausing a proteasome inhibition assay. J. Nat. Prod. 2004, 67(11), 1911-1914.
90. Yang, H.; Shi, G.; Dou, Q. P. The tumor proteasome is a primarytarget for the natural anticancer compound Withaferin A isolatedfrom Indian winter cherry. Mol. Pharmacol. 2007, 71(2), 426-437.
91. Maity, R.; Sharma, J.; Jana, N. R. Capsaicin induces apoptosisthrough ubiquitin-proteasome system dysfunction. J. Cell. Biochem.2010, 109(5), 933-942
92. Yang, H.; Chen, D.; Cui, Q. C.; Yuan, X.; Dou, Q. P. Celastrol, atriterpene extracted from the Chinese Thunder of God Vine, is apotent proteasome inhibitor and suppresses human prostate cancergrowth in nude mice. Cancer Res. 2006, 66(9), 4758-4765.
93. Zhang, H. G.; Kim, H.; Liu, C.; Yu, S.; Wang, J.; Grizzle, W. E.;Kimberly, R. P.; Barnes, S. Curcumin reverses breast tumorexosomes mediated immune suppression of NK cell tumor cytotoxicity. Biochim. Biophys. Acta 2007, 1773(7), 1116-1123.
94. Wyke, S. M.; Russell, S. T.; Tisdale, M. J. Induction of proteasomeexpression in skeletal muscle is attenuated by inhibitors of NFkappaBactivation. Br. J. Cancer 2004, 91(9), 1742-1750.
95. Lev-Ari, S.; Strier, L.; Kazanov, D.; Madar-Shapiro, L.; Dvory-Sobol, H.; Pinchuk, I.; Marian, B.; Lichtenberg, D.; Arber, N.Celecoxib and curcumin synergistically inhibit the growth of colorectalcancer cells. Clin. Cancer Res. 2005, 11(18), 6738-6744.
96. Bava, S. V.; Puliappadamba, V. T.; Deepti, A.; Nair, A.; Karunagaran,D.; Anto, R. J. Sensitization of taxol-induced apoptosis by curcumininvolves down-regulation of nuclear factor-kappaB and theserine/threonine kinase Akt and is independent of tubulin polymerization. J. Biol. Chem. 2005, 280(8), 6301-6308.
97. Notarbartolo, M.; Poma, P.; Perri, D.; Dusonchet, L.; Cervello, M.;D'Alessandro, N. Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancercells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression. Cancer Lett. 2005, 224(1), 53-65.
98. Chirnomas, D.; Taniguchi, T.; de la Vega, M.; Vaidya, A. P.;Vasserman, M.; Hartman, A. R.; Kennedy, R.; Foster, R.; Mahoney,J.; Seiden, M. V.; D'Andrea, A. D. Chemosensitization tocisplatin by inhibitors of the Fanconi anemia/BRCA pathway. Mol.Cancer Ther. 2006, 5(4), 952-961.
99. Maher, P. The flavonoid fisetin promotes nerve cell survival fromtrophic factor withdrawal by enhancement of proteasome activity.Arch. Biochem. Biophys. 2008, 476(2), 139-144.
100. Salmela, A. L.; Pouwels, J.; Varis, A.; Kukkonen, A. M.;Toivonen, P.; Halonen, P. K.; Perala, M.; Kallioniemi, O.; Gorbsky,G. J.; Kallio, M. J. Dietary flavonoid fisetin induces a forcedexit from mitosis by targeting the mitotic spindle checkpoint. Carcinogenesis 2009, 30(6), 1032-1040.
101. Kazi, A.; Daniel, K. G.; Smith, D. M.; Kumar, N. B.; Dou, Q. P.Inhibition of the proteasome activity, a novel mechanism associatedwith the tumor cell apoptosis-inducing ability of genistein.Biochem. Pharmacol. 2003, 66(6), 965-976.
102. Yu, Z.; Li, W.; Liu, F. Inhibition of proliferation and induction ofapoptosis by genistein in colon cancer HT-29 cells. Cancer Lett.2004, 215(2), 159-166.
103. Singletary, K.; Ellington, A. Genistein suppresses proliferation and MET oncogene expression and induces EGR-1 tumor suppressor expression in immortalized human breast epithelial cells. Anticancer Res. 2006, 26(2A), 1039-1048.
104. Jeong, J. H.; An, J. Y.; Kwon, Y. T.; Li, L. Y.; Lee, Y. J. Quercetin-induced ubiquitination and down-regulation of Her-2/neu. J.Cell. Biochem. 2008, 105(2), 585-595.
105. Psahoulia, F. H.; Moumtzi, S.; Roberts, M. L.; Sasazuki, T.;Shirasawa, S.; Pintzas, A. Quercetin mediates preferential degradationof oncogenic Ras and causes autophagy in Ha-RAStransformedhuman colon cells. Carcinogenesis 2007, 28(5), 1021-1031.
106. Kim, J. Y.; Kim, E. H.; Park, S. S.; Lim, J. H.; Kwon, T. K.; Choi,K. S. Quercetin sensitizes human hepatoma cells to TRAILinducedapoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation. J. Cell. Biochem. 2008, 105(6), 1386-1398.
107. Shakibaei, M.; Csaki, C.; Nebrich, S.; Mobasheri, A. Resveratrol suppresses interleukin-1beta-induced inflammatory signaling and apoptosis in human articular chondrocytes: potential for use as anovel nutraceutical for the treatment of osteoarthritis. Biochem.Pharmacol. 2008, 76(11), 1426-1439.
108. Delmas, D.; Lancon, A.; Colin, D.; Jannin, B.; Latruffe, N. Resveratrolas a chemopreventive agent: a promising molecule forfighting cancer. Curr. Drug Targets 2006, 7(4), 423-442.